/ Life Sciences Equipment and Consumables / Case Study

Bio-Pharma Sterile RTP Transfer

The client is mainly engaged in R&D of oncolytic virus varieties. 3 advantages of oncolytic virus M1, its core product, are intravenous injection, precision treatment and lyophilized preparation. The company is globally leading in the field of oncolytic virus segmentation. In order to achieve continuous manufacturing of filling isolators, materials must be transferred aseptically.

AUSTAR Solution

• Various Beta combinations (SS beta valve and RDB, RTP barrel, liquid transportation bag) to achieve efficient and fast transportations. • Basing on client's process requirements, a customized integrated solution was generated from scheme design, implementation until validation documents.

Highlights

First case in China of a full-range RTP aseptic transfer solution for isolators.

Multiple Beta combinations enable efficient and rapid aseptic transfer.

Customized integrated solution covering design, implementation, and validation.

AUSTAR Value & Client Benefits

To assist the new drug launching, cross departments of AUSTAR closely collaborated with client's R&D and Production Departments to carry out multiple technical exchanges. As a result, we successfully implemented the first case of aseptic transportation solution by using full range of RTP products for isolators in China. It solved the client's transportation challenge and greatly supported their successful development of new drugs.
Go Back Read More

Contact Us

This site uses cookies. To see how cookies are used, please review our Cookies Policy here.

Reject
Accept